Group 2392.png

KISQALI® + NSAI maintained QoL vs. NSAI alone at 3 years*1

 

 

Group 2360.png

 

 

*The EORTC QLQ-C30 incorporates 5 functional scales (physical, role, cognitive, emotional, and social), 3 symptom scales (fatigue, pain, and nausea and vomiting), a global health status/QoL scale, and a number of single items.2
†No difference from baseline was observed in either arm based on established thresholds for interpreting changes in physical functioning score (−5 to 2, no difference).

 

eBC, early breast cancer; EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer, core quality of life questionnaire; HR-QoL, health-related quality of life; NSAI, non-steroidal aromatase inhibitor; QoL, quality of life.

KISQALI® NSS - UAE

PDF
View

References

  1. Fasching PA, et al. Abstract VP3-2023. Presented at the American Society of Clinical Oncology 2023, 2–6 June, Chicago, USA. 2. Aaronson NK, et al. J Natl Cancer Inst. 1993;85(5):365–376.